(Q34663202)

English

Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species (English)

1 reference

Europe PubMed Central

3 August 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Han Ma

1

1 reference

Europe PubMed Central

3 August 2017

Wen-Rong Jiang

2

1 reference

Europe PubMed Central

3 August 2017

Nicole Robledo

3

1 reference

Europe PubMed Central

3 August 2017

Vincent Leveque

4

1 reference

Europe PubMed Central

3 August 2017

Samir Ali

5

1 reference

Europe PubMed Central

3 August 2017

Teresa Lara-Jaime

6

1 reference

Europe PubMed Central

3 August 2017

Mohammad Masjedizadeh

7

1 reference

Europe PubMed Central

3 August 2017

David B Smith

8

1 reference

Europe PubMed Central

3 August 2017

Nick Cammack

9

1 reference

Europe PubMed Central

3 August 2017

Klaus Klumpp

10

1 reference

Europe PubMed Central

3 August 2017

Julian Symons

11

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

13 August 2007

1 reference

Europe PubMed Central

3 August 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

3 August 2017

282

1 reference

Europe PubMed Central

3 August 2017

41

1 reference

Europe PubMed Central

3 August 2017

29812-29820

1 reference

Europe PubMed Central

3 August 2017

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Hepatitis C Virus RNA Synthesis in a Cell-Free System Isolated from Replicon-Containing Hepatoma Cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Inhibition of native hepatitis C virus replicase by nucleotide and non-nucleoside inhibitors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Nucleoside and nucleotide inhibitors of HIV-1 replication.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Structure-activity relationship of heterobase-modified 2'-C-methyl ribonucleosides as inhibitors of hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

In vitro selected Con1 subgenomic replicons resistant to 2'-C-methyl-cytidine or to R1479 show lack of cross resistance

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Design, synthesis, and antiviral properties of 4'-substituted ribonucleosides as inhibitors of hepatitis C virus replication: the discovery of R1479.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Mechanism of Activation of -D-2'-Deoxy-2'-Fluoro-2'-C-Methylcytidine and Inhibition of Hepatitis C Virus NS5B RNA Polymerase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Design, synthesis, and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methylcytidine, a potent inhibitor of hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Inhibitory Effect of 2'-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon Cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Nucleoside analog inhibitors of hepatitis C virus replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M705274200

21 January 2018

Identifiers

10.1074/JBC.M705274200

1 reference

Europe PubMed Central

3 August 2017

release_n5u7dfdz3jcpzazriuw6jrx5vm

1 reference

https://api.fatcat.wiki/v0/release/n5u7dfdz3jcpzazriuw6jrx5vm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34663202&oldid=1838892295"